ARATANA THERAPEUTICS INC. overview

Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health Aratana Reports Voting Results from 2019 Special Meeting of Stockholders PR Newswire LEAWOOD, Kan., July 16, 2019 LEAWOOD, Kan. , July 16, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the three proposals considered and voted upon by its...

Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders Stockholders Elect All Class III Directors and Approve Proposals PR Newswire LEAWOOD, Kan., June 7, 2019 LEAWOOD, Kan. , June 7, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the four proposals considered and voted upon by its...

Aratana Therapeutics Reports First Quarter 2019 Financial Results Continued revenue growth across portfolio of marketed pet therapeutics PR Newswire LEAWOOD, Kan., May 8, 2019 LEAWOOD, Kan. , May 8, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, announced its first quarter 2019 financial results and recent business highlights. "I am very pleased that we...

Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference PR Newswire LEAWOOD, Kan., May 7, 2019 LEAWOOD, Kan. , May 7, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, plans on presenting at the Stifel Dental & Veterinary Conference on Wednesday, May 29, 2019 at 8:00 a.m. ET in New York City . Interested parties may listen to the webcast...

...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aratana Therapeutics, Inc. PR Newswire NEW YORK, April 26, 2019 NEW YORK , April 26, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Aratana Therapeutics, Inc. (NASDAQ: PETX) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Elanco Animal Health Incorporated (NYSE: ELAN). Stockholders will receive 0.1481 shares of Elanco Animal Health common...

Aratana Therapeutics to be Acquired by Elanco Animal Health Elanco announces formation of commercial team dedicated to veterinary specialty business PR Newswire LEAWOOD, Kan., April 26, 2019 LEAWOOD, Kan. , April 26, 2019 /PRNewswire/ -- Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, announced it has signed an agreement to be acquired by Elanco Animal Health (NYSE: ELAN), its global...

Aratana Therapeutics to Report First Quarter 2019 Financial Results PR Newswire LEAWOOD, Kan., April 22, 2019 LEAWOOD, Kan. , April 22, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Wednesday, May 8 at 4:30 p.m. ET to discuss financial results from the first quarter ended March 31, 2019 . Interested participants and...